1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of genomic alterations in adenosquamous carcinoma of the pancreas (ASCOP)
    Meeting Abstract

    Jordan, E.; Basturk, O.; Leach, S. D.; Klimstra, D. S.; Allen, P. J.; Berger, M. F.; Askan, G.; Yu, K. H.; O'Reilly, E. M.; Lowery, M. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • BRAF mutations in patients with large cell neuroendocrine carcinoma of the colon (LCNECC)
    Meeting Abstract

    Ganesh, K.; Raj, N. P.; Yaeger, R. D.; Berger, M. F.; Shia, J.; Reidy, D. L.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Clinical prognostic factors and genomic analysis of ovary metastases (mets) from colorectal cancer (CRC)
    Meeting Abstract

    Ganesh, K.; Shah, R.; Vakiani, E.; Kemeny, N. E.; Lincoln, A.; Tran, C.; Varghese, A. M.; Yaeger, R. D.; Cercek, A.; Segal, N. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Hepatic adenoma among adult survivors of childhood cancer
    Meeting Abstract

    Tonorezos, E. S.; Barnea, D.; Abou-Alfa, G. K.; Bromberg, J.; D'Angelica, M. I.; Sklar, C. A.; Oeffinger, K. C.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic landscape of pancreatic adenocarcinoma: Does age matter?
    Meeting Abstract

    Ben-Aharon, I.; Elkabets, M.; Pelossof, R.; Yu, K. H.; Allen, P. J.; Iacobuzio-Donahue, C. A.; Leach, S. D.; Lowery, M. A.; Goodman, K. A.; O'Reilly, E. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling and efficacy of anti-EGFR therapy in appendiceal adenocarcinoma
    Meeting Abstract

    Braghiroli, M.; Nash, G. M.; Morris, M.; Hechtman, J. F.; Vakiani, E.; Berger, M. F.; Solit, D. B.; Saltz, L.; Cercek, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study
    Meeting Abstract

    Friedman, D. N.; Wolden, S. L.; Antal, Z.; Moskowitz, C. S.; Hilden, P.; Cheung, N. K. V.; Kushner, B. H.; Tonorezos, E. S.; Carlow, D.; Oeffinger, K. C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with (89)Zr-Df-IAB2M in metastatic prostate cancer (PCa)
    Meeting Abstract

    Morris, M. J.; Martinez, D. F.; Durack, J. C.; Slovin, S. F.; Danila, D. C.; O'Donoghue, J. A.; Parada, N. A.; Lyashchenko, S. K.; Carrasquillo, J. A.; Ruan, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Differential overall survival (OS) results in RECORD-3 study based on three distinct mRCC molecular subgroups classified by BAP1 and/or PBRM1 mutations
    Meeting Abstract

    Hsieh, J.; Chen, D.; Wang, P.; Chen, Y.; Marker, M.; Patel, P.; Chevinsky, M.; Bhanot, U.; Pinciroli, P.; Berger, M. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • [(18)F] NaF PET/CT imaging biomarkers of progression-free survival in metastatic prostate cancer
    Meeting Abstract

    Harmon, S.; Perk, T.; Eickhoff, J. C.; Staab, M. J.; Choyke, P. L.; Dahut, W. L.; Apolo, A. B.; Humm, J.; Larson, S. M.; Morris, M. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save